Literature DB >> 3661138

Successful treatment with bromocriptine of hypertension associated with polycystic ovarian disease.

M Ito1, K Matsuura, A Aiko, K Matsui, T Yoshimura, H Okamura.   

Abstract

The use of bromocriptine, 5 mg per day, markedly improved the severe hypertension (up to 180/120 mmHg) of a patient suffering from polycystic ovarian disease (PCOD). The response was rapid, with decreasing concentrations of serum testosterone and 11-deoxycorticosterone (DOC). Bromocriptine induced further renewal of the ovulatory cycle. Bromocriptine may thus be of considerable value in the treatment hypertensive patients with PCOD.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3661138     DOI: 10.3109/00016348709020764

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand        ISSN: 0001-6349            Impact factor:   3.636


  1 in total

1.  Bromocriptine, a Dopamine (d2) Receptor Agonist, Used Alone and in Combination with Glipizide in Sub-Therapeutic Doses to Ameliorate Hyperglycaemia.

Authors:  Harish Kumar V S; Vinutha M B; Pradeep A N; Sathisha Aithal; Sindhura Reddy Baleed; Umakant N Patil
Journal:  J Clin Diagn Res       Date:  2013-09-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.